Hall Laurie J Trustee Clovis Oncology, Inc. Transaction History

Hall Laurie J Trustee

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 04, 2021	SELL	$4.06 - $5.8 $1,258 - $1,798	-310 Reduced 37.8%	510 $2,000
Q3 2020 Oct 09, 2020	BUY	$4.82 - $7.72 $2,554 - $4,091	530 Added 182.76%	820 $5,000
Q4 2019 Feb 12, 2020	BUY	$3.0 - $16.43 $870 - $4,764	290 New	290 $3,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Hall Laurie J Trustee, based on Form 13F filings with the SEC.

Stay updated on Hall Laurie J Trustee with notifications on news.